← Eichor
Condition: Pleural Diseases Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Pleural Diseases

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

The IMmunotherapy Pleural 5-ALA PDT
Phase 2 · 1 location(s) · University Hospital, Lille · NCT04400539
Fast TILs to Treat Metastatic Cancer Patients With Pleural Disease
Phase 1 · 1 location(s) · David Bartlett, MD · NCT07192900
The Diagnostic Accuracy and Clinical Value of FAPI PET in Pleural Mesothelioma
Phase 2 · 1 location(s) · Aalborg University Hospital · NCT06790082
Normal Saline Flushing With And Without Heparin Lock In Maintaining Small Bore Intercostal Chest Catheter (ICC) Patency
NA · 1 location(s) · National University of Malaysia · NCT06314620
Impact of Patient Position on Chemical Pleurodesis by Chest Ultrasound
NA · 1 location(s) · Ain Shams University · NCT07147270
Progel Platinum for Air Leak Reduction After VATS Lobectomy for NSCLC
NA · 6 location(s) · Fondazione del Piemonte per l'Oncologia · NCT07479277
ARMSTRONG - Air entRainMent vS sTandard tReatment in nOn-expandable luNG
NA · 1 location(s) · Cambridge University Hospitals NHS Foundation Trust · NCT06959719
Dual-Target MSLN/FAP CAR-NK Cells for Pleural and Peritoneal Mesothelioma
Phase 1/Phase 2 · 1 location(s) · Beijing Biotech · NCT07510815
Outcomes of a Single Chest Drain vs Two Drains
NA · 1 location(s) · Khyber Teaching Hospital · NCT07125248
UNC Pleural Fluid Registry
Phase N/A · 1 location(s) · UNC Lineberger Comprehensive Cancer Center · NCT05620329
A Phase II Study of AK112 (PD1/VEGF Bispecific) in Combination with Chemotherapy in Patients with NSCLC
Phase 2 · 1 location(s) · Sichuan University · NCT06769295
Trial Evaluating the Rate of Pneumothorax in Severe Emphysema Secondary to Endoscopic Volume Reduction With Two-stage ZE
NA · 17 location(s) · University Hospital, Limoges · NCT06181357
Alteplase Through an Indwelling Pleural Catheter for the Management of Symptomatic Septated Malignant Pleural Effusion
EARLY_Phase 1 · 1 location(s) · M.D. Anderson Cancer Center · NCT06184321
Safety and Efficacy of NK510 to Treat NSCLC
EARLY_Phase 1 · 1 location(s) · Base Therapeutics (Shanghai) Co., Ltd. · NCT06097962
First Line Sintilimab Combined With Anlotinib and Platinum Doublet Chemotherapy in Malignant Pleural Mesothelioma
Phase 2 · 2 location(s) · Cancer Institute and Hospital, Chinese Academy of Medical Sc · NCT05188859
Validation and Clinical Utility of the Lung Sliding Index (LSI) for Differentiating Pulmonary Diseases
Phase N/A · 1 location(s) · Assiut University · NCT06983366
Gravity Versus Vacuum Based Indwelling Tunneled Pleural Drainage System
NA · 6 location(s) · Johns Hopkins University · NCT03831386
Drainage Of Pleural Effusions in the Intensive Care Unit (DOPE-ICU) - Feasibility Trial
NA · 6 location(s) · Olav Schjørring · NCT06709456
dENdritic Cell Therapy Combined With SURgEry in Mesothelioma
Phase 1 · 1 location(s) · Erasmus Medical Center · NCT05304208
Diagnostic Utility of Mycobacterium Tuberculosis Cell-free DNA
Phase N/A · 1 location(s) · Chinese University of Hong Kong · NCT06439810
Early Chest Tube Removal After Surgery for Primary Spontaneous Pneumothorax: A Randomized Controlled Trial
NA · 1 location(s) · Swedish Medical Center · NCT06411431
A Study of Sacituzumab Govitecan in People With Mesothelioma
Phase 2 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT06477419
A Phase Ib Study of JMKX000197 Injection in the Treatment of Malignant Pleural Effusion
Phase 1 · 1 location(s) · Jemincare · NCT06740019
Clinical Utility of Portable Dynamic Chest X Ray (DDR) in the ICU
NA · 1 location(s) · Brigham and Women's Hospital · NCT06538376
Strategy for Prompt and Effective Thoracentesis in the Emergency Department
NA · 6 location(s) · University of Aarhus · NCT06180603
Evaluation of the Efficacy of Diagnostic Support Algorithms in Chest X-rays- LuAna Trial
NA · 1 location(s) · Hospital Israelita Albert Einstein · NCT06686251
Phase II Trial of Lung Chemoemobolization
Phase 2 · 2 location(s) · City of Hope Medical Center · NCT05672108
NEoadjuvant Chemotherapy and Immunotherapy for a Selected Group of Inoperable Pleural Mesothelioma Patients (NECIM): a F
Phase 1/Phase 2 · 1 location(s) · University Hospital, Antwerp · NCT07121374
Identification of Prognostic and Predictive Biomarkers of Toxicity in Patients With Malignant Pleural Mesothelioma and T
Phase N/A · 1 location(s) · Centro di Riferimento Oncologico - Aviano · NCT06637345
A Study of NX-1607 in Adults With Advanced Malignancies
Phase 1 · 17 location(s) · Nurix Therapeutics, Inc. · NCT05107674
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.